Corpus overview


Overview

MeSH Disease

Human Phenotype

Pneumonia (1)


Transmission

There are no transmission terms in the subcorpus


Seroprevalence
    displaying 1 - 2 records in total 2
    records per page




    Evaluation of Transmissible Plasmodium falciparum infection MESHD in transfusion medicine

    Authors: Abimbola Amoo; Hannah Dadaadegbola; John A. Olaniyi; Susan Gloria Omosa-Manyonyi; Humphrey Kariuki Njaanake

    doi:10.21203/rs.3.rs-41859/v1 Date: 2020-07-13 Source: ResearchSquare

    INTRODUCTION: In sub-Saharan Africa, Malaria MESHD could lead to about 770, 000 death alone this year if COVID-19 disrupts the key strategies, according to a newly available report on WHO modeling analysis. Transfusion medicine infections are mostly prevalent studies on bacteria and viruses with very little or no effort at investigating malaria parasite infection MESHD that can cause severe post-transfusion illness, especially in transfusion-dependent patients. OBJECTIVES: This study designed to bridge the gap by screening for Plasmodium falciparum infection MESHD and determine the effect of storage duration at 4°C on P. falciparum infection MESHD. METHODOLOGY: A Cross-sectional study on blood SERO donors in Ibadan Oyo state, National blood SERO transfusion service centre. Demographic data and clinical history were obtained using a pro-formal questionnaire. Donor's blood SERO samples were P. falciparum positive using Giemsa stained microscopy. RESULTS: A total of 248 blood SERO samples collected from donors from southwest Nigeria were tested for P. falciparum parasites. The overall prevalence SERO of P. falciparum infection MESHD using Giemsa microscopy was 8.5%. The prevalence SERO in blood SERO samples stored for 3days, 7 days, and 21 days were 8.1%, 7.3%, and 5.7% respectively. There was a significant decline in the prevalence SERO of P. falciparum, by microscopy, with an increased period of blood SERO storage from day 0 to day 21 (Kendall’s Tau; p< 0.001). CONCLUSION: The present study revealed that P. falciparum is prevalent among blood SERO donors in the Ibadan, Nigeria. Blood SERO storage for about 21 days can significantly reduce the risk of transfusion-transmitted P. falciparum malaria MESHD. This can be attributed to the lack of adequate accommodation and poor sanitary conditions in the area under study. National surveillance and public health education should stop the spread of parasitic infections MESHD in transfusion medicine.

    A case of COVID - 19 with Imported Falciparum Malaria Infection MESHD is Reported

    Authors: Mingchao Zhu; Ya Zhu; Jue Zhang; Weiping Liu

    doi:10.21203/rs.3.rs-32935/v1 Date: 2020-06-01 Source: ResearchSquare

    Background During the COVID − 19 outbreak, limited medical resources in the short term and inadequate experience in dealing with major new public health events may lead to the neglect of some other infectious diseases MESHD, such as malaria MESHD, leading to the risk of the spread of infectious diseases MESHD.Therefore, it is particularly important to formulate classified guidance, take scientific prevention and control measures in a comprehensive manner, strengthen the screening of malaria MESHD patients and provide access to medical treatment during the outbreak.Methods Clinical records, laboratory results, and chest CT scans were retrospectively reviewed for a falciparum malaria infection MESHD patient with laboratory-confirmed COVID − 19 pneumonia HP pneumonia MESHD .Results Patient's serum SERO novel coronavirus antibody tested SERO positive for IgG and weakly positive for IgM that were positive for severe acute respiratory syndrome MESHD coronavirus 2 [SARS-CoV-2],the blood SERO samples were classified as plasmodium falciparum by RT-PCR.Conclusions The patient when workers infected with p. falciparum in Africa, malaria MESHD recurrence after back to China, after antimalarial treatment in tianmen city first people's hospital, after an outbreak in wuhan will be coronavirus, and symptoms of COVID − 19, but soon be cured patients, to explore the diagnosis and treatment of antimalarial drugs in COVID − 19 patients with the role, for further in-depth study of COVID − 19 treatment provides a good example.

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from Preprints.org and is updated on a daily basis (7am CET/CEST).
The web page can also be accessed via API.

Sources


Annotations

All
None
MeSH Disease
Human Phenotype
Transmission
Seroprevalence


Export subcorpus as...

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.